Fractalkine/CX ₃CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death

Neuroscience

• Neuron 100%
• Fractalkine 63%
• Morphine 36%
• Glia 27%
• HIV 22%
• Striatum 18%
• Western Blot 13%
• Opioid 9%
• Eicosanoid Receptor 4%
• Protein 4%
• Antibodies 4%
• Neurotoxicity 4%
• Neuroprotection 4%
• Neuroprotective Agent 4%
• Microglia 4%
• ELISA 4%
• Fluorescence 4%
• Opiate 4%
• Immunofluorescence 4%
• Co-Receptor 4%

Medicine and Dentistry

• Morphine 36%
• Toxicity 18%
• Human Immunodeficiency Virus 18%
• Death 13%
• Opiate 13%
• Cells 9%
• Receptor 9%
• Inflammatory Mediator 4%
• Combination Therapy 4%
• Antibody 4%
• Protein 4%
• Interpersonal Communication 4%
• Surveillance 4%
• Cell Type 4%
• Enzyme Linked Immunosorbent Assay 4%
• Microglia 4%
• Human Immunodeficiency Virus Infection 4%
• Neuroprotective Agent 4%
• Cellular Mechanism 4%
• Neuroprotection 4%
• Immunoreactivity 4%
• Neurotoxicity 4%
• Microscopy 4%

Biochemistry, Genetics and Molecular Biology

• Human Immunodeficiency Virus 22%
• Wild Type 13%
• Tumor Necrosis Factor 9%
• Mouse 4%
• Microscopy 4%
• Time 4%
• Electric Potential 4%
• Mediator 4%
• Cell Culture 4%
• Interpersonal Communication 4%
• Knockout Mouse 4%
• Contrast 4%
• Fluorescence 4%
• Microglia 4%
• Immunoreactivity 4%
• Immunofluorescence 4%
• Co-Receptor 4%